subscribeSubscribe
price-trendAsk Us
Prilenia: Huntington`s, ALS Pridopidine Data At AAN 2024

Prilenia: Huntington`s, ALS Pridopidine Data At AAN 2024
BUSINESSWIRE
12 Apr 2024
Share Share
Prilenia Plans to Submit MAA in the EU for Pridopidine in Huntington’s Disease

Prilenia Plans to Submit MAA in the EU for Pridopidine in Huntington’s Disease
BUSINESSWIRE
12 Mar 2024
Share Share
Aural Speech Technology Signaled Slowing of Decline in ALS Patients’ Speech

Aural Speech Technology Signaled Slowing of Decline in ALS Patients’ Speech
BUSINESSWIRE
24 Feb 2023
Share Share
Prilenia searches for positive signs in phase 2 ALS fail

Prilenia searches for positive signs in phase 2 ALS fail
Annalee Armstrong FIERCE BIOTECH
23 Feb 2023
Share Share
Prilenia Completes Enrollment Ahead of Schedule in HEALEY ALS Platform Trial

Prilenia Completes Enrollment Ahead of Schedule in HEALEY ALS Platform Trial
BUSINESSWIRE
05 Jan 2022
Share Share
Prilenia Receives FTD for Pridopidine for Huntington’s Disease

Prilenia Receives FTD for Pridopidine for Huntington’s Disease
BUSINESSWIRE
17 Nov 2021
Share Share
Prilenia Announces First Patient Enrolled for Pridopidine Ph2/3 Platform

Prilenia Announces First Patient Enrolled for Pridopidine Ph2/3 Platform
BUSINESSWIRE
08 Jan 2021
Share Share